Nikolai Lorenzen

Nikolai Lorenzen has extensive experience in the field of biophysics and injectable formulation at Novo Nordisk, serving in various roles including Principal Scientist, Director, Head of Department, Specialist, Senior Scientist, and Research Scientist since January 2014. Prior to this, Nikolai was a PhD student in the Protein Biophysics Group at Aarhus University from September 2009 to November 2013 and worked as a project employee at Aarhus University Hospital in June 2008. Nikolai holds a Doctor of Philosophy (Ph.D.) in Protein Biophysics from Aarhus University, a Master of Science (MSc) in Nanoscience from Aarhus University, a Master of Science (MSc) in Protein and Peptide Chemistry from Stockholm University, and a Bachelor of Science (B.Sc.) in Biotechnology Engineering from Aalborg University.